FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205859093> ?p ?o ?g. }

• W4205859093 abstract "Abstract Background: Metastatic pheochromocytomas are rare neuroendocrine tumors that carry a poor prognosis. There are no curative treatments; however, current therapeutic strategies to control tumor burden include surgery, radiation, ablative therapy, chemoembolization, and systemic therapies. We describe an interesting case of a patient with metastatic pheochromocytoma misdiagnosed as renal cell carcinoma (RCC) started on axitinib and pembrolizumab, who achieved a partial response to treatment, despite lack of approved indications for these therapies in metastatic pheochromocytoma. Clinical Case: A 64-year-old man presented to the emergency department (ED) with uncontrolled hypertension and severe headache. A 12 cm left-sided pheochromocytoma was diagnosed 11 years ago, which was surgically resected via adrenalectomy. After surgery, the patient was followed in the endocrine clinic for five years with pheochromocytoma serum biochemical markers and declared free of disease. 2 months before hospital admission, he was worked-up for flank pain and at that time, CT abdomen showed a 3 cm mass in the liver and exophytic solid mass measuring 4.2 cm off the left kidney. Subsequently, a CT guided biopsy of the left renal mass was performed and revealed grade II renal cell carcinoma (RCC). He was referred to oncology and was started on a combination of IV pembrolizumab, an immune checkpoint inhibitor against PD-1/PD-L1, and oral axitinib, a selective VEGF receptor inhibitor. He received 3 cycles of immunotherapy treatment; however, he became significantly hypertensive with intermittent headaches, so he was started on atenolol 25 mg once daily. Despite this, he continued to have uncontrolled hypertension, worsening headaches, and flushing, which prompted him to undergo evaluation in the ED. On arrival, BP was 210/90. Labs were remarkable for Hgb 17.2, WBC count of 17.1, and glucose of 178 mg/dL. CT head was negative for any acute intracranial process. Due to suspected recurrence of pheochromocytoma, atenolol was stopped, adrenal workup was conducted, and the patient was started on doxazosin. Urine metanephrines came back elevated at 1097 (RR: 55-320 μg/24 hrs), urine norepinephrine of 260 (RR: 14-120 μg/24 hrs), and urine normetanephrine of 3305 (RR: 114-865 μg/24 hrs). Re-evaluation of pathology opinion was obtained, which indicated that biopsy stained positive for chromogranin A and synaptophysin markers, consistent with metastatic pheochromocytoma. FDG PET/CT was performed following discharge, which revealed the left renal mass decreased to 2.4 cm and the liver mass shrunk to 1.5 cm. Conclusion: To our knowledge, this is the first case report outside of a clinical trial highlighting partial response to axitinib and pembrolizumab in metastatic pheochromocytoma. Emerging preliminary phase II clinical trial data are currently investigating these medications as future treatment modalities." @default.
• W4205859093 created "2022-01-26" @default.
• W4205859093 creator A5055903175 @default.
• W4205859093 creator A5076680187 @default.
• W4205859093 creator A5083799224 @default.
• W4205859093 creator A5088233212 @default.
• W4205859093 creator A5088600847 @default.
• W4205859093 date "2021-05-01" @default.
• W4205859093 modified "2023-10-06" @default.
• W4205859093 title "A Surprising Outcome of Metastatic Pheochromocytoma Misdiagnosed as Renal Cell Carcinoma: A Case Report" @default.
• W4205859093 doi "https://doi.org/10.1210/jendso/bvab048.2023" @default.
• W4205859093 hasPublicationYear "2021" @default.
• W4205859093 type Work @default.
• W4205859093 citedByCount "0" @default.
• W4205859093 crossrefType "journal-article" @default.
• W4205859093 hasAuthorship W4205859093A5055903175 @default.
• W4205859093 hasAuthorship W4205859093A5076680187 @default.
• W4205859093 hasAuthorship W4205859093A5083799224 @default.
• W4205859093 hasAuthorship W4205859093A5088233212 @default.
• W4205859093 hasAuthorship W4205859093A5088600847 @default.
• W4205859093 hasBestOaLocation W42058590931 @default.
• W4205859093 hasConcept C121608353 @default.
• W4205859093 hasConcept C126322002 @default.
• W4205859093 hasConcept C141071460 @default.
• W4205859093 hasConcept C2776539811 @default.
• W4205859093 hasConcept C2777472916 @default.
• W4205859093 hasConcept C2777701055 @default.
• W4205859093 hasConcept C2779490328 @default.
• W4205859093 hasConcept C2779512018 @default.
• W4205859093 hasConcept C2780030458 @default.
• W4205859093 hasConcept C2780057760 @default.
• W4205859093 hasConcept C2780091579 @default.
• W4205859093 hasConcept C2780227381 @default.
• W4205859093 hasConcept C71924100 @default.
• W4205859093 hasConceptScore W4205859093C121608353 @default.
• W4205859093 hasConceptScore W4205859093C126322002 @default.
• W4205859093 hasConceptScore W4205859093C141071460 @default.
• W4205859093 hasConceptScore W4205859093C2776539811 @default.
• W4205859093 hasConceptScore W4205859093C2777472916 @default.
• W4205859093 hasConceptScore W4205859093C2777701055 @default.
• W4205859093 hasConceptScore W4205859093C2779490328 @default.
• W4205859093 hasConceptScore W4205859093C2779512018 @default.
• W4205859093 hasConceptScore W4205859093C2780030458 @default.
• W4205859093 hasConceptScore W4205859093C2780057760 @default.
• W4205859093 hasConceptScore W4205859093C2780091579 @default.
• W4205859093 hasConceptScore W4205859093C2780227381 @default.
• W4205859093 hasConceptScore W4205859093C71924100 @default.
• W4205859093 hasLocation W42058590931 @default.
• W4205859093 hasLocation W42058590932 @default.
• W4205859093 hasOpenAccess W4205859093 @default.
• W4205859093 hasPrimaryLocation W42058590931 @default.
• W4205859093 hasRelatedWork W13397619 @default.
• W4205859093 hasRelatedWork W1411949 @default.
• W4205859093 hasRelatedWork W20800172 @default.
• W4205859093 hasRelatedWork W21505035 @default.
• W4205859093 hasRelatedWork W2605758 @default.
• W4205859093 hasRelatedWork W272120 @default.
• W4205859093 hasRelatedWork W7110753 @default.
• W4205859093 hasRelatedWork W7384862 @default.
• W4205859093 hasRelatedWork W7529559 @default.
• W4205859093 hasRelatedWork W894444 @default.
• W4205859093 isParatext "false" @default.
• W4205859093 isRetracted "false" @default.
• W4205859093 workType "article" @default.